InvestorsObserver
Sign Up Login

CSPCY Cspc Pharmaceutical Group Ltd AD

$3.44 $0.00 (0.00%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

CSPCY Stock Analysis Overview

What this means: Cspc Pharmaceutical Group Ltd AD (CSPCY) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives CSPCY a rank of 17. Our methodology considers analysis of the company's financial situation and how it has traded recently. CSPCY rank of 17 means that it ranks below 83% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

CSPCY Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

CSPCY Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

CSPCY Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

CSPCY Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

CSPCY Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

CSPCY Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

CSPCY Stock Analysis Overview

What this means: Cspc Pharmaceutical Group Ltd AD (CSPCY) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives CSPCY a rank of 17. Our methodology considers analysis of the company's financial situation and how it has traded recently. CSPCY rank of 17 means that it ranks below 83% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full CSPCY report

CSPCY Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

CSPCY Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

CSPCY Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

CSPCY Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

CSPCY Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

CSPCY Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Cspc Pharmaceutical Group Ltd AD (CSPCY) Analyst Forecast

CSPCY Price, Volume, Earnings, and Dividend Date

  • Last Price $3.44
  • Previous Close $3.44
  • Change $0.00
  • Open $3.40
  • Volume 11,170
  • Avg. Volume (100-day) 32,477
  • Market Cap 10,253,538,970
  • Days Range 3.4003 - 3.44
  • 52-week Range 2.63 - 4.08
  • Dividend Yield 1.67%
  • Ex. Dividend Date 05/31/24
  • P-E —
  • EPS —
  • Earnings Date —
  • Sector Healthcare
  • Industry Drug Manufacturers - General
  • Avg. Analyst Rec. Premium
  • Beta 1.455
  • PEG Ratio —

Cspc Pharmaceutical Group Ltd AD (CSPCY) Company Description

CSPC Pharmaceutical Group, or CSPC, is one of the largest drug manufacturers in China. The company has a diversified portfolio of generic drugs, bulk drugs, and drugs with improved formulations. Its R&D pipeline is focused on cardio-cerebrovascular diseases, digestion and metabolic diseases, oncology, neurology, and anti-infectives.

Cspc Pharmaceutical Group Ltd AD (CSPCY) Stock Chart

View Interactive CSPCY chart

My Watchlists

Top Stocks in Drug Manufacturers - General